Skip to main content
Top
Published in: Cardiovascular Toxicology 3/2017

01-07-2017

Flecainide Toxicity: A Case Report and Systematic Review of its Electrocardiographic Patterns and Management

Authors: Michael A. Valentino, Andrew Panakos, Loheetha Ragupathi, Janna Williams, Behzad B. Pavri

Published in: Cardiovascular Toxicology | Issue 3/2017

Login to get access

Abstract

In the setting of flecainide toxicity, supraventricular tachycardia can manifest as a bizarre right or left bundle branch block, sometimes with a northwest axis, and can easily be mistaken for ventricular tachycardia leading to inappropriate therapy. We conducted a comprehensive literature review for cases of flecainide toxicity. We found 21 articles of flecainide toxicity in adult patients in which 22 ECG tracings were published. In patients with flecainide toxicity and QRS duration ≤ 200 ms, the ECGs were more likely to show RBBB, visible P waves (p = 0.03), and shorter QT (p = 0.02) and QTc intervals (p = 0.004). With QRS duration > 200 ms, the ECGs were more likely to show LBBB, loss of P waves, a northwest axis (p = 0.01), and longer QT and QTc intervals. Deaths were reported only in patients with QRS duration >200 ms, and the outcome of death or requirement for mechanical circulatory support was more prevalent in patients with a QRS duration > 200 ms [2/13 (15.4 %) vs. 6/10 (60 %), p = 0.04]. In patients with access to the medication, flecainide toxicity should be suspected with: (1) broad QRS, (2) RBBB morphology with QRS ≤ 200 ms; RBBB or LBBB morphology with QRS ≥ 200 ms (3) HR out of proportion to the degree of hemodynamic instability. The duration of the QRS interval is prognostic, with mortality and the requirement for mechanical circulatory support being more common in patients with a QRS > 200 ms.
Appendix
Available only for authorised users
Literature
1.
go back to reference January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cleveland, J. C., Cigarroa, J. E., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 64(21), 2246–2280.CrossRef January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cleveland, J. C., Cigarroa, J. E., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 64(21), 2246–2280.CrossRef
2.
go back to reference Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., et al. (2012). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. European Heart Journal, 33(21), 2719–2747.CrossRefPubMed Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., et al. (2012). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. European Heart Journal, 33(21), 2719–2747.CrossRefPubMed
3.
go back to reference Blomström-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., et al. (2003). ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology. Circulation, 108(15), 1871–1909.CrossRefPubMed Blomström-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., et al. (2003). ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology. Circulation, 108(15), 1871–1909.CrossRefPubMed
4.
go back to reference Winkelmann, B. R., & Leinberger, H. (1987). Life-threatening flecainide toxicity. A pharmacodynamic approach. Annals of Internal Medicine, 106(6), 807–814.CrossRefPubMed Winkelmann, B. R., & Leinberger, H. (1987). Life-threatening flecainide toxicity. A pharmacodynamic approach. Annals of Internal Medicine, 106(6), 807–814.CrossRefPubMed
5.
go back to reference Devin, R., Garrett, P., & Anstey, C. (2007). Managing cardiovascular collapse in severe flecainide overdose without recourse to extracorporeal therapy. Emergency Medicine Australasia, 19(2), 155–159.CrossRefPubMed Devin, R., Garrett, P., & Anstey, C. (2007). Managing cardiovascular collapse in severe flecainide overdose without recourse to extracorporeal therapy. Emergency Medicine Australasia, 19(2), 155–159.CrossRefPubMed
6.
go back to reference Köppel, C., Oberdisse, U., & Heinemeyer, G. (2008). Clinical course and outcome in class IC antiarrhythmic overdose. Journal of Toxicology - Clinical Toxicology, 28(4), 433–444.CrossRef Köppel, C., Oberdisse, U., & Heinemeyer, G. (2008). Clinical course and outcome in class IC antiarrhythmic overdose. Journal of Toxicology - Clinical Toxicology, 28(4), 433–444.CrossRef
7.
go back to reference Crijns, H. J., van Gelder, I. C., & Lie, K. I. (1988). Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. American Journal of Cardiology, 62(17), 1303–1306.CrossRefPubMed Crijns, H. J., van Gelder, I. C., & Lie, K. I. (1988). Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. American Journal of Cardiology, 62(17), 1303–1306.CrossRefPubMed
8.
go back to reference Courand, P.-Y. N., Sibellas, F., Ranc, S., Mullier, A., Kirkorian, G., & Bonnefoy, E. (2013). Arrhythmogenic effect of flecainide toxicity. Cardiology Journal, 20(2), 203–205.CrossRefPubMed Courand, P.-Y. N., Sibellas, F., Ranc, S., Mullier, A., Kirkorian, G., & Bonnefoy, E. (2013). Arrhythmogenic effect of flecainide toxicity. Cardiology Journal, 20(2), 203–205.CrossRefPubMed
9.
go back to reference Bou-Abboud, E., & Nattel, S. (1996). Relative role of alkalosis and sodium ions in reversal of class I antiarrhythmic drug induced sodium channel blockade by sodium bicarbonate. Circulation, 94(8), 1954–1961.CrossRefPubMed Bou-Abboud, E., & Nattel, S. (1996). Relative role of alkalosis and sodium ions in reversal of class I antiarrhythmic drug induced sodium channel blockade by sodium bicarbonate. Circulation, 94(8), 1954–1961.CrossRefPubMed
10.
go back to reference Weinberg, G. L., VadeBoncouer, T., Ramaraju, G. A., Garcia-Amaro, M. F., & Cwik, M. J. (1998). Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology, 88(4), 1071–1075.CrossRefPubMed Weinberg, G. L., VadeBoncouer, T., Ramaraju, G. A., Garcia-Amaro, M. F., & Cwik, M. J. (1998). Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology, 88(4), 1071–1075.CrossRefPubMed
11.
go back to reference Litonius, E. (2012). Treatment of acute intoxication with intravenous lipid emulsion: animal and human studies. Helsinki: University of Helsinki. Litonius, E. (2012). Treatment of acute intoxication with intravenous lipid emulsion: animal and human studies. Helsinki: University of Helsinki.
12.
go back to reference Ellsworth, H., Stellpflug, S. J., Cole, J. B., Dolan, J. A., & Harris, C. R. (2013). A life-threatening flecainide overdose treated with intravenous fat emulsion. Pacing and Clinical Electrophysiology, 36(3), e87–e89.CrossRefPubMed Ellsworth, H., Stellpflug, S. J., Cole, J. B., Dolan, J. A., & Harris, C. R. (2013). A life-threatening flecainide overdose treated with intravenous fat emulsion. Pacing and Clinical Electrophysiology, 36(3), e87–e89.CrossRefPubMed
13.
go back to reference Sivalingam, S. K., Gadiraju, V. T., Hariharan, M. V., Atreya, A. R., Flack, J. E., & Aziz, H. (2013). Flecainide toxicity—Treatment with intravenous fat emulsion and extra corporeal life support. Acute Cardiac Care, 15(4), 90–92.CrossRefPubMed Sivalingam, S. K., Gadiraju, V. T., Hariharan, M. V., Atreya, A. R., Flack, J. E., & Aziz, H. (2013). Flecainide toxicity—Treatment with intravenous fat emulsion and extra corporeal life support. Acute Cardiac Care, 15(4), 90–92.CrossRefPubMed
Metadata
Title
Flecainide Toxicity: A Case Report and Systematic Review of its Electrocardiographic Patterns and Management
Authors
Michael A. Valentino
Andrew Panakos
Loheetha Ragupathi
Janna Williams
Behzad B. Pavri
Publication date
01-07-2017
Publisher
Springer US
Published in
Cardiovascular Toxicology / Issue 3/2017
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-016-9380-0

Other articles of this Issue 3/2017

Cardiovascular Toxicology 3/2017 Go to the issue